Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Investing

More Evidence That Opioid Policymakers Keep Aiming at the Wrong Target

by May 30, 2023
May 30, 2023

Jeffrey A. Singer

A new study released earlier this year adds more evidence to the mountains of evidence that policymakers trying to solve the overdose crisis have been aiming at the wrong target.

Researchers from the Dartmouth University School of Medicine recently published in the Annals of Surgery the results of a prospective clinical trial of 221 opioid naïve surgical patients prescribed opioids at discharge and followed for one year after surgery. Eighty‐​eight percent of the patients had cancer‐​related operations. Their surgeons prescribed opioids for pain control when they discharged them home from the hospital. The researchers accessed the Prescription Drug Monitoring Program (PDMP) to monitor the patients’ long‐​term opioid use.

Their findings: 15.3 percent filled opioid prescriptions 3–12 months after their initial surgery. Six percent of the time, it was because of pain related to the initial (“index”) operation, but 51 percent of the time, it was due to a new painful condition, and 40 percent from undergoing another surgery. The remaining 2.3 percent (five patients) filled opioid prescriptions one year later because of chronic pain due to recurrent cancer (two), a new medical condition (two), and a chronic abscess (one). Only one patient filled an opioid prescription 12 months post‐​hospital discharge for no specific reason. The researchers noted that patients disposed of their leftover opioids at a high rate. They concluded:

In a group of prospectively studied opioid‐​naïve surgical patients discharged with guideline‐​directed opioid rxs and who achieved high rates of excess opioid disposal, no patients became persistent opioid users solely as a result of the opioid rx given after their index surgery. Long‐​term opioid use did occur for other, well‐​defined, medical or surgical reasons.

This latest study adds to a January 2018 study in BMJ by researchers at Harvard and Johns Hopkins that examined 568,000 opioid naïve patients prescribed opioids for acute and postoperative pain from 2008 to 2016. The researchers found a total “misuse” rate (all “misuse” diagnostic codes) of just 0.6 percent.

It also supports the result of a prospective study of emergency room patients sent home with prescription opioids for pain and followed for six months, published in the Annals of Emergency Medicine in May 2020. That study found that one percent (five patients) met the criteria for persistent opioid use by the end of the follow‐​up period. Four of the five patients still had moderate or severe pain in the affected body part six months after release from the emergency department.

As I and my co‐​authors reported in the Journal of Pain Research in January 2019, there is no correlation between opioid prescription volume and the non‐​medical use of or addiction to prescription opioids. And data from the National Survey on Drug Use and Health shows that the addiction rate among persons aged 18 and above has remained essentially unchanged throughout the 21st century, with the percentage addicted to prescription painkillers hovering at around 0.7 percent from 2002 through 2014, despite prescription rates surging to record highs in the early 2000s and then, after 2012, dropping more than 60 percent.

It seems that no amount of evidence will convince policymakers to abandon the false narrative that doctors treating their patients’ pain caused the overdose crisis. This refusal causes many patients to needlessly suffer while driving non‐​medical users of diverted black‐​market prescription pain pills to illicit fentanyl.

Lawmakers and policymakers, blind to the evidence that drug prohibition is the primary cause of the overdose crisis, have given us the worst of both worlds: patients inadequately treated for pain while overdose deaths soar.

0
FacebookTwitterGoogle +Pinterest
previous post
Sector Spotlight: Will Tech Take a Seasonal Break in June?
next post
The Continuing Effort to Deny that Libertarian‐​ish Voters Exist

You may also like

The Phonics Resurgence

June 14, 2023

USPS: Privatize Not Bureaucratize

February 21, 2025

Massive Cost Overrun on Renewable Energy Project

November 15, 2023

Six Questions on Donald Trump’s Conviction

June 18, 2024

Reforming Medicaid Subsidies

October 13, 2023

High Court Approves California’s Pork Production Standards

May 12, 2023

Friday Feature: UrbaNeXt

March 22, 2024

Are Bump Stock Bans Useful?

June 28, 2024

Solar Panels and Open Lands

November 6, 2024

As the Public Schooling Battle Map Passes 4,000...

April 5, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • House of Lords AI summit at London Tech Week warns of ‘skills cliff edge’ threatening UK’s competitive future

      June 11, 2025
    • Tariff tensions force Spain’s food giants to seek markets beyond the US

      June 11, 2025
    • Sizewell C secures £14.2bn state boost – but energy savings won’t come for a decade

      June 11, 2025
    • Michelle Mone-linked PPE firm faces £122m high court battle with government

      June 11, 2025
    • Entrepreneur turned away from London Tech Week for bringing baby sparks industry backlash

      June 11, 2025
    • Global economy faces bleak outlook as World Bank warns of worst decade since 1960s

      June 11, 2025

    Categories

    • Business (8,183)
    • Investing (2,027)
    • Politics (15,591)
    • Stocks (3,141)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved